Gross Margin
31.53%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 21.46%.Updated Aug 21, 2026Profit Margin
-29.85%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Margin
6.51%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Assets (TTM)
0.13%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Equity (TTM)
-16.30%vs Specialty Chemicals peers Updated Aug 21, 2026Revenue (TTM)
798.14MCNY118.69M · vs all stocks (USD) Updated Aug 21, 2026Revenue per Share (TTM)
1.84CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-28.50%vs Specialty Chemicals peers Updated Aug 21, 2026Gross Profit (TTM)
171.26MCNY25.47M · vs all stocks (USD) Updated Aug 21, 2026EBITDA (TTM)
105.75MCNY15.73M · vs all stocks (USD) Updated Aug 21, 2026Net Income (TTM)
-238.23MCNY-35.43M · vs all stocks (USD) Updated Aug 21, 2026Quarterly Earnings Growth (YoY)
-50.87%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Cash Flow (TTM)
174.86MCNY26.00M · vs all stocks (USD) Updated Aug 21, 2026Levered Free Cash Flow (TTM)
219.81MCNY32.69M · vs all stocks (USD) Updated Aug 21, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 21, 2026Minority Interest (Equity)
21.11MCNYFY2025 · Dec 31, 2025Revenue
860.63MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
672.01MCNYFY2025 · Dec 31, 2025Gross Profit
188.62MCNYFY2025 · Dec 31, 2025Operating Income
14.18MCNY2.11M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-228.02MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.55MCNYFY2025 · Dec 31, 2025Net Income
-240.57MCNYFY2025 · Dec 31, 2025EBIT
-214.75MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
105.75MCNYFY2025 · Dec 31, 2025Research & Development
28.97MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
48.38MCNYFY2025 · Dec 31, 2025Other Operating Expenses
13.49MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.61MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
13.27MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.5900CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.5900CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
413.80MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
413.80MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-240.57MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-3.57MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-88.79MCNYFY2025 · Dec 31, 2025Free Cash Flow
-161.54MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
196.74MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-240.57MCNYFY2025 · Dec 31, 2025Other Non-cash Items
18.35MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
103.30MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
30.14MCNYFY2025 · Dec 31, 2025Capital Expenditures
-72.75MCNYFY2025 · Dec 31, 2025Purchase of Investments
-182.88MCNYFY2025 · Dec 31, 2025Sale of Investments
205.55MCNYFY2025 · Dec 31, 2025Other Investing Activity
1.08MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-49.00MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
330.81MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-512.89MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-13.49MCNYFY2025 · Dec 31, 2025Other Financing Charges
4.14MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-191.42MCNYFY2025 · Dec 31, 2025